Published in Basic Res Cardiol on October 30, 2003
Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. Circ Res (2010) 4.19
In vivo properties of the proangiogenic peptide QK. J Transl Med (2009) 1.26
Injectable extracellular matrix derived hydrogel provides a platform for enhanced retention and delivery of a heparin-binding growth factor. Acta Biomater (2012) 1.05
Redox-dependent mechanisms in coronary collateral growth: the "redox window" hypothesis. Antioxid Redox Signal (2009) 1.01
Bioreducible polymer-transfected skeletal myoblasts for VEGF delivery to acutely ischemic myocardium. Biomaterials (2010) 0.96
Identification of ARIA regulating endothelial apoptosis and angiogenesis by modulating proteasomal degradation of cIAP-1 and cIAP-2. Proc Natl Acad Sci U S A (2009) 0.94
Genetic modification of stem cells for transplantation. Adv Drug Deliv Rev (2007) 0.93
Normalization of coronary blood flow in the infarct-related artery after intracoronary progenitor cell therapy: intracoronary Doppler substudy of the TOPCARE-AMI trial. Clin Res Cardiol (2006) 0.88
Polymer transfected primary myoblasts mediated efficient gene expression and angiogenic proliferation. J Control Release (2009) 0.88
A novel autologous cell-based therapy to promote diabetic wound healing. Ann Surg (2012) 0.85
A specific subpopulation of mesenchymal stromal cell carriers overrides melanoma resistance to an oncolytic adenovirus. Stem Cells Dev (2012) 0.85
Expansion of microvascular networks in vivo by phthalimide neovascular factor 1 (PNF1). Biomaterials (2008) 0.84
Mechanistic exploration of phthalimide neovascular factor 1 using network analysis tools. Tissue Eng (2007) 0.83
Avidity-controlled delivery of angiogenic peptides from injectable molecular-recognition hydrogels. Tissue Eng Part A (2014) 0.81
Circulating Natural IgM Antibodies Against Angiogenin in the Peripheral Blood Sera of Patients with Osteosarcoma as Candidate Biomarkers and Reporters of Tumorigenesis. Biomark Cancer (2010) 0.78
[Angiogenesis. Possibilities for therapeutic intervention in rheumatic diseases]. Z Rheumatol (2007) 0.75
A novel bFGF-GH injection therapy for two patients with severe ischemic limb pain. J Anesth (2008) 0.75
Pharmacologically preconditioned skeletal myoblasts are resistant to oxidative stress and promote angiomyogenesis via release of paracrine factors in the infarcted heart. Circ Res (2007) 2.64
Supportive interaction between cell survival signaling and angiocompetent factors enhances donor cell survival and promotes angiomyogenesis for cardiac repair. Circ Res (2006) 1.64
Ex vivo delivered stromal cell-derived factor-1alpha promotes stem cell homing and induces angiomyogenesis in the infarcted myocardium. J Mol Cell Cardiol (2007) 1.61
Evidence for ischemia induced host-derived bone marrow cell mobilization into cardiac allografts. J Mol Cell Cardiol (2006) 1.41
Retracted Myoblast transplantation for cardiac repair: from automyoblast to allomyoblast transplantation. Ann Thorac Surg (2008) 1.39
Strategies for directing the differentiation of stem cells into the cardiomyogenic lineage in vitro. Cardiovasc Res (2004) 1.29
Diazoxide potentiates mesenchymal stem cell survival via NF-kappaB-dependent miR-146a expression by targeting Fas. Am J Physiol Heart Circ Physiol (2010) 1.20
Transplantation of nanoparticle transfected skeletal myoblasts overexpressing vascular endothelial growth factor-165 for cardiac repair. Circulation (2007) 1.13
Cardiac tumorigenic potential of induced pluripotent stem cells in an immunocompetent host with myocardial infarction. Regen Med (2011) 1.08
Sonic Hedgehog gene delivery to the rodent heart promotes angiogenesis via iNOS/netrin-1/PKC pathway. PLoS One (2010) 1.08
Preconditioning promotes survival and angiomyogenic potential of mesenchymal stem cells in the infarcted heart via NF-kappaB signaling. Antioxid Redox Signal (2010) 1.07
Adult stem cells for cardiac repair: a choice between skeletal myoblasts and bone marrow stem cells. Exp Biol Med (Maywood) (2006) 1.03
Efficient non-viral reprogramming of myoblasts to stemness with a single small molecule to generate cardiac progenitor cells. PLoS One (2011) 1.02
Mobilized bone marrow progenitor cells serve as donors of cytoprotective genes for cardiac repair. J Mol Cell Cardiol (2007) 1.02
Mitochondria-specific transgenic overexpression of connexin-43 simulates preconditioning-induced cytoprotection of stem cells. Cardiovasc Res (2010) 0.98
Improved angiogenic response in pig heart following ischaemic injury using human skeletal myoblast simultaneously expressing VEGF165 and angiopoietin-1. Eur J Heart Fail (2006) 0.96
MicroRNA-21 is a key determinant in IL-11/Stat3 anti-apoptotic signalling pathway in preconditioning of skeletal myoblasts. Cardiovasc Res (2010) 0.95
Nonviral vector-based gene transfection of primary human skeletal myoblasts. Exp Biol Med (Maywood) (2007) 0.89
Non-hypoxic stabilization of HIF-Iα during coordinated interaction between Akt and angiopoietin-1 enhances endothelial commitment of bone marrow stem cells. J Mol Med (Berl) (2012) 0.87
Cell-based VEGF delivery prevents donor cell apoptosis after transplantation. Ann Thorac Surg (2007) 0.84
Therapeutic angiogenesis for treatment of peripheral vascular disease. Growth Factors (2004) 0.84
Autologous skeletal myoblasts transduced with a new adenoviral bicistronic vector for treatment of hind limb ischemia. J Vasc Surg (2004) 0.83
Cell-based ex vivo delivery of angiogenic growth factors for cardiac repair. Arterioscler Thromb Vasc Biol (2005) 0.83
Reversal of myocardial injury using genetically modulated human skeletal myoblasts in a rodent cryoinjured heart model. Eur J Heart Fail (2005) 0.82
Angiopoietin-1 for myocardial angiogenesis: a comparison between delivery strategies. Eur J Heart Fail (2006) 0.81
In vitro functional assessment of human skeletal myoblasts after transduction with adenoviral bicistronic vector carrying human VEGF165 and angiopoietin-1. J Heart Lung Transplant (2005) 0.81
Dose-dependent effect of aprotinin on aggravated pro-inflammatory cytokines in patients with pulmonary hypertension following cardiopulmonary bypass. Cardiovasc Drugs Ther (2003) 0.81
Myoblast-based cardiac repair: xenomyoblast versus allomyoblast transplantation. J Thorac Cardiovasc Surg (2007) 0.80
Adenoviral short hairpin RNA therapy targeting phosphodiesterase 5a relieves cardiac remodeling and dysfunction following myocardial infarction. Am J Physiol Heart Circ Physiol (2012) 0.80
Angiomyogenesis using liposome based vascular endothelial growth factor-165 transfection with skeletal myoblast for cardiac repair. Biomaterials (2008) 0.79
Activation of IL-11/STAT3 pathway in preconditioned human skeletal myoblasts blocks apoptotic cascade under oxidant stress. Regen Med (2012) 0.79
Neuropeptide y and neuropeptide y y5 receptor interaction restores impaired growth potential of aging bone marrow stromal cells. Rejuvenation Res (2011) 0.78
Preconditioning of Human Skeletal Myoblast with Stromal Cell-derived Factor-1α Promotes Cytoprotective Effects against Oxidative and Anoxic Stress. Int J Stem Cells (2011) 0.77
Liposome-based vascular endothelial growth factor-165 transfection with skeletal myoblast for treatment of ischaemic limb disease. J Cell Mol Med (2008) 0.76
High efficiency transduction of human VEGF165 into human skeletal myoblasts: in vitro studies. Exp Mol Med (2003) 0.76
Role of pharmacologically mobilized endogenous bone marrow stem cells for cardiac repair. J Heart Lung Transplant (2005) 0.75
Avoiding compliance with histocompatibility dogma using immune privileged cell xenografts. Ann Thorac Surg (2003) 0.75
RE: Heng BC, Tong c: the differentiation status of stem cells and their derivatives: A key consideration in transplantation medicine. ASAIO J 50: 626-627, 2004. ASAIO J (2005) 0.75
Cellular myocardial reconstruction using human myoblasts. J Am Coll Cardiol (2003) 0.75
Immunosuppression and xenotransplantation of cells for cardiac repair. Ann Thorac Surg (2004) 0.75
Developing "super cells" by modification with super anti-apoptotic factor. J Mol Cell Cardiol (2006) 0.75
New strategy for cardiac repair: genetically modified skeletal myoblasts. Asian Cardiovasc Thorac Ann (2007) 0.75
Cardioprotective effect of des-Aspartate-angiotensin-I (DAA-I) on cytokine gene expression profile in ligation model of myocardial infarction. Life Sci (2006) 0.75